Soluprep S is a drug owned by 3m Health Care Infection Prevention Div. It is protected by 1 US drug patent filed in 2018 out of which none have expired yet. Based on its patents and exclusivities, its generic launch date is estimated to be Jul 26, 2029. Details of Soluprep S's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US8623935 | Antimicrobial compositions |
Jul, 2029
(4 years from now) | Active |
FDA has granted several exclusivities to Soluprep S. Till the time these exclusivities are active, no other company can market a generic or bioequivalent version of Soluprep S, regardless of the status of it's patents. These exclusivities hence play a crucial role in delaying the generic launch. Given below are details of the exclusivities granted to Soluprep S.
Exclusivity Information
Soluprep S holds 2 exclusivities out of which 1 have expired. Its last outstanding exclusivity is set to expire in 2026. Details of Soluprep S's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Aug 08, 2021 |
| M(M-292) | Jan 20, 2026 |
US patents provide insights into the exclusivity only within the United States, but Soluprep S is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Soluprep S's family patents as well as insights into ongoing legal events on those patents.
Soluprep S's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Soluprep S's generic launch date based on the last expiry date of its patents and exclusivities combined is estimated to be Jul 26, 2029 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Soluprep S Generics:
There are no approved generic versions for Soluprep S as of now.
Alternative Brands for Soluprep S
Soluprep S which is used for reducing bacteria on the skin prior to surgery to prevent potential infections., has several other brand drugs in the same treatment category and using the same active ingredient (Chlorhexidine Gluconate; Isopropyl Alcohol). Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | Treatment Area | ||
|---|---|---|---|---|
| Sage Prods |
| |||
Apart from drugs working in same treatment category, there are also some brand drugs where treatment area is different, but the active ingredient used is same i.e. Chlorhexidine Gluconate; Isopropyl Alcohol. Given below is the list of those drugs and companies owning them.
| Drug Owner | Drug Name | ||||
|---|---|---|---|---|---|
| Becton Dickinson Co |
| ||||
| Prof Dspls |
|
About Soluprep S
Soluprep S is a drug owned by 3M Health Care Infection Prevention Div. It is used for reducing bacteria on the skin prior to surgery to prevent potential infections. Soluprep S uses Chlorhexidine Gluconate; Isopropyl Alcohol as an active ingredient. Soluprep S was launched by 3M Health Care in 2018.
Approval Date:
Soluprep S was approved by FDA for market use on 08 August, 2018.
Active Ingredient:
Soluprep S uses Chlorhexidine Gluconate; Isopropyl Alcohol as the active ingredient. Check out other Drugs and Companies using Chlorhexidine Gluconate; Isopropyl Alcohol ingredient
Treatment:
Soluprep S is used for reducing bacteria on the skin prior to surgery to prevent potential infections.
Dosage:
Soluprep S is available in solution form for topical use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 2%;70% | SOLUTION | Over the counter | TOPICAL |